PAD Rehabilitation Toolkit A Guide for Healthcare Professionals Healthy Steps for Peripheral Artery Disease (PAD) Developed by AACVPR and the Vascular.

Slides:



Advertisements
Similar presentations
Peripheral Arterial Disease Mehul Bhatt, MD Interventional Cardiology / Vascular Medicine Athens Heart Center.
Advertisements

Peripheral Artery Occlusive Disease
Peripheral Arterial Disease >Increasing Awareness >What is PAD >Risk factors >Symptoms of PAD >Screening & Treatment Options.
The Cramping Leg Management of peripheral vascular disease
Peripheral Vascular Disease in Cardiac Patients
Epidemiology of Peripheral Vascular Disease Sohail Ahmed School of Population and Health Sciences.
What You Will Do Identify changeable risk factors that can lead to diseases of the heart and lungs. Explain diseases that can result from certain lifestyles.
PAD A Call to Action. PAD: A Call to Action - What is peripheral arterial disease (PAD)? and why is it so dangerous? - Diagnosing PAD in the primary care.
The Diagnosis and Treatment of Peripheral Vascular Disease
Dharam J. Kumbhani, MD, SM, MRCP, Ph. Gabriel Steg, MD, Christopher P. Cannon, MD, Kim A Eagle, MD, Sidney C. Smith, Jr., MD, Shinya Goto, MD, Cannon,
,000 20,00030,000 Rest Normal 50% Lesion 90% 75% Work of the Heart (double product) Coronary Blood Flow.
BASICS OF CARDIORESPIRATORY ENDURANCE Chapter 7 Lesson 1 & 2.
Stay in Circulation Facts About Peripheral Arterial Disease (P.A.D.) A National Public Awareness Campaign from the P.A.D. Coalition and the National Heart,
Phlebitis and thrombophlebitis
PERIPHERAL VASCULAR DISEASE: A VASCULAR SURGEON’S POINT OF VIEW
Elise Wood Stress Management. Narrowing of the walls of the arteries Excessive plaque build up Disrupts blood flow Potential cardiovascular complications.
Unit # 5 Cardiovascular Disease. Cardiovascular Disease Overview #1 cause of mortality in Canada Laboratory Centre for Disease Control; Statistics Canada,
Management of Dyslipidemia in Patients with Peripheral Arterial Disease: an update from Guidelines Oman International Vascular Conference Al-Bustan Palace.
Cardiac Rehabilitation Are you or someone you know missing the benefits of Cardiac Rehabilitation? July
Special Report Peripheral Arterial Disease: Lack of Awareness in Canada The First Canadian P.A.D. Public Awareness Survey Peripheral Arterial Disease:
20 Cardiovascular Disease and Physical Activity chapter.
December Cardiac Rehabilitation Are you or someone you know missing the benefits of Cardiac Rehabilitation?
Atherosclerosis.
STROKE STATS Third leading cause of death deaths a year strokes a year stroke survivors Leading cause of adult disability Source:
New guidelines for CABG
Understanding Heart Disease In this lesson, you will Learn About… Different types of heart disease. How heart disease is treated. What you can do to reduce.
Cardiovascular Disease
Peripheral Artery Disease (PAD) & Ankle Brachial Index (ABI) Marge Lovell RN CCRC CVN BEd MEd London Health Sciences Centre London, Ontario, Canada.
PAD AND VASCULAR EVENTS  IC AS A DISEASE OFTEN REMAINS UN RECOGNISED. AS HIGH AS 75% OF PEOPLE WHO HAVE IC DO NOT SEEK MEDICAL HELP SINCE MANY PEOPLE.
Post-Surgical Care for the Individual With PAD: A Shared Responsibility to Sustain Life and Limb.
Look Closer Improving understanding of the leading cause of heart attack and stroke.
Cause : lipid rich plaque; calcified coronary lesion Location of vessel : native coronary artery; renal artery Laterality : Left; Right; bilateral Specificity,
Amjad AlMahameed, MD, MPH Division of Cardiology Beth Israel Deaconess Medical Center Boston Differentiating Lower Extremity Pain: Arteries, Veins, and.
Cardiovascular Disease (CVD) CVD affects the heart (cardio) and blood vessels (vascular).
1 “Diabetic foot” Sensory Autonomic Motor. 2 Neuropathic: 45-60% Purely ischaemic: 10% Mixed neuroischaemic: 25-40% Diabetic foot ulceration.
Lancet 373: , 2009 Baseline Characteristics of Participants and Study Design of Clinical Trials to Compare Intensive glucose- lowering versus.
CARDIOVASCULAR DISEASE. 2 parts Heart (Cardio) Blood Vessels (Vascular)
ACC/AHA 2006 guidelines on the management of PAD.
Pathophysiology BMS 243 Vascular Diseases Lecture IV Dr. Aya M. Serry
Higher Human Biology.  CVD is responsible for a huge proportion of deaths annually.
The Vicious Cycle. International Diabetes Federation What Causes CVD in Diabetes? Atherosclerosis Hypertension AND Microangiopathy Neuropathy Damage to.
Medical Management of Claudication: Just Walk it Off!!
Antithrombotic Therapy in Peripheral Artery Disease Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy and Prevention.
Relative Risk vs the General Population ReducedIncreased Diabetes Smoking Hypertension Total cholesterol (10 mg/dL)
Peripheral Artery Disease in Orthopaedic Patients with Asymptomatic Popliteal Artery Calcification on Plain X-ray Adam Podet, MS; Julia Volaufova, phD,;
Cardiovascular Disease (CVD) Objectives: Describe the movement of blood through the cardiovascular system Discuss the prevalence of CVD Define the types.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Frequency and Practice-Level Variation in Inappropriate.
HOW THE HEART WORKS BLOOD FLOW THROUGH THE HEART.
Atherosclerosis By Aravind Kalathil, Sam Eiswirth, and Brooke Turner.
Peripheral Artery Disease (PAD)
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Next Steps in Primary Prevention of Coronary Heart.
PAD DR. SHWETA PHADKE..
Long-Term Comparative Outcomes of Patients With Peripheral Artery Disease With and Without Concomitant Coronary Artery Disease   Debbie C. Chen1, Gagan.
Peripheral Interventions in the VA Healthcare System
CVD Part 2.
Antithrombotic Therapy in Peripheral Artery Disease
Single Stage CABG and Peripheral Arterial Bypass for Combined Coronary and Peripheral Arterial Disease Divya Arora, Ashok Chahal and Shamsher Singh Lohchab.
The pathology of cardiovascular disease (CVD)
Peripheral Arterial Disease
Post-Surgical Care for the Individual With PAD
Prashant Kaul, MD, FSCAI Piedmont Heart Institute, Atlanta, GA
Medical Therapy for Peripheral Artery Disease
Public Health Burden of CAD/PAD
EUCLID Trial design: Patients with peripheral arterial disease (PAD) were randomized to ticagrelor 90 mg twice daily (n = 6,930) vs. clopidogrel 75 mg.
366 میلیون نفر در جهان مبتلا به دیابت هستند.
Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization 
What You Will Do Identify changeable risk factors that can lead to diseases of the heart and lungs. Explain diseases that can result from certain lifestyles.
Baseline Characteristics of Cardiovascular Risk Factors and Selected Dietary Variables in a Cohort of 22,881 Men and 35,091 Women to Quintile of Fish Intakes.
Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization 
Cardiovascular Epidemiology and Epidemiological Modelling
Presentation transcript:

PAD Rehabilitation Toolkit A Guide for Healthcare Professionals Healthy Steps for Peripheral Artery Disease (PAD) Developed by AACVPR and the Vascular Disease Foundation

What is PAD? Peripheral artery disease (PAD) results from systemic atherosclerosis and involves blood vessels throughout the body however, PAD is most commonly used in reference to lower extremity disease.

About PAD PAD symptoms result from limited arterial blood flow, which causes debilitating, activity-induced, ischemic pain (intermittent claudication) PAD is associated with major limitations in mobility and physical functioning, and decreased quality of life Not all persons with PAD have symptoms Subsequent risk for other manifestations of CVD (heart attack and stroke) is high

Belch, J. J. F. et al. Arch Intern Med 2003;163: Common PAD Risk Factors

Clinical Presentation of PAD Hirsch AT et al. J Am Coll Cardiol. 2006;47: Initial clinical presentation Asymptomatic PAD 20%–50% Atypical leg pain 40%–50% Claudication 10%–35% Critical Limb Ischemia (CLI) 1%–2% PAD Population (  50 years)

Two Major Goals in Treating Participants with PAD Limb Outcomes Cardiovascular Morbidity and Mortality Outcomes Relieve Symptoms Increase in peak walking distance Improvement in quality-of-life indicators Prevention of progression to CLI and amputation Decrease mortality/morbidity from MI, stroke, and cardiovascular death

Essentials of Management for PAD: Reduce Symptoms and Lower Risk for Coronary Artery Disease and Stroke Risk Factor Normalization Tobacco use – Goal complete cessation Lipid management – Goal LDL <100 mg/dL Blood pressure control – Goal <140/90 mm Hg – Goal <130/80 mm Hg (hypertension + diabetes or renal disease) Blood sugar control (patients with diabetes) – Goal A1C <7% Ant platelet Therapies Clopidogrel, ASA Symptom-Directed Therapies Supervised exercise rehabilitation Cilostazol Selective use of revascularization

Intermittent Claudication (IC) “Claudicatio” (Latin: “to limp”) Claudius was known to limp A symptom of PAD characterized by pain, aching, or fatigue in exercising leg muscles It can be thought of as ANGINA of the legs

Differential Diagnosis of Leg Pain (Other Potential Causes) Spinal canal stenosis Peripheral neuropathy Peripheral nerve pain – Herniated disc impinging on sciatic nerve Osteoarthritis of the hip or knee Venous claudication Symptomatic Baker’s cyst Chronic compartment syndrome Muscle spasms or cramps Restless leg syndrome Also see Table 3 of Hirsch AT, et al. J Am Coll Cardiol. 2006;47:e1-e192.

Diagnosing PAD Understanding the ABI TASC Working Group. J Vasc Surg ABI= Ankle Systolic Pressure/Brachial Artery Systolic Pressure Example: 120mmHg/140mmHg = 0.86 Hirsch AT. Fam Pract Recert ABIInterpretation Normal Borderline Mild to Moderate <0.40Severe >1.30Non-Compressible Vessels

The Cycle of Disability in Intermittent Claudication peripheral artery disease Reduced oxygen Endothelial dysfunction Ischemic Reperfusion Systematic inflammation Free radical generation Deconditioning and worsening: Obesity, Hypertension Hyperlipidemia Hyperglycemia Thrombotic risk Altered muscle metabolism Acylcarnitine accumulation Altered electron transport Impaired walking ability Decreased quality of life Muscle fiber denervation Muscle fiber atrophy Altered myosin heavy chain expression Poor aerobic capacity Reduced muscle strength and endurance

PAD versus CAD Exercise Rehabilitation PADCAD Participants with PAD often remain at the same level of walking impairment for several years There is often spontaneous recovery after MI, CABG, or PTCA Because symptoms remain stable, exercise goals are to relieve symptoms, improve functional status, and increase walking ability Phase II (early) cardiac rehabilitation is more focused on recovery from an acute event Participants need to walk to leg pain to gain benefit Chest pain is a contradiction to exercise

Benefits of Exercise Training in Participants with PAD and IC Supervised exercise training increases – functional capacity greater walking distance before experiencing symptoms – quality of life Functional benefits are greatest when – exercise sessions last longer than 30 minutes – sessions take place at least 3 times per week – walking into leg pain – the program lasts 6 months or longer

Role Of Direct Supervision Supervision increases the likelihood that the exercise session will be carried out according to guidelines As participants improve their walking ability, the exercise workload should be increased by increasing treadmill grade or speed (or both), to assure that there is always the stimulus of claudication pain during the workout As participants increase their walking ability, there is the possibility that cardiac signs and symptoms may appear as they achieve higher heart rates and blood pressures Additional monitoring is determined by clinical responses Stewart, Hiatt, Regensteiner, Hirsch. NEJM 347: December 12, 2002.

Potential Mechanisms for Exercise-Induced Improvements Improved oxygen extraction and utilization by exercising muscle Improved endothelial function Improved blood rheology Improved gait and walking economy Increased tolerance to pain Possibly increased blood supply

Mechanisms by Which Exercise May Improve Function & Symptoms in Claudication Stewart, Hiatt, Regensteiner, Hirsch. NEJM 347: December 12, peripheral artery disease Reduced oxygen Endothelial dysfunction Ischemic Reperfusion Systematic inflammation Free radical generation Deconditioning and worsening: Obesity, Hypertension Hyperlipidemia Hyperglycemia Thrombotic risk Altered muscle metabolism Acylcarnitine accumulation Altered electron transport Impaired walking ability Decreased quality of life Muscle fiber denervation Muscle fiber atrophy Altered myosin heavy chain expression Poor aerobic capacity Reduced muscle strength and endurance Effects of exercise training on pathophysiological correlates of claudication Good evidence for improvement Potential improvement Short-term: may worsen Long-term: may improve

Goals of Medical Evaluation Before Exercise Rehabilitation To confirm diagnosis of PAD and IC To confirm absence of – Critical limb ischemia – Unstable angina – Decompensated heart failure – Uncontrolled cardiac arrhythmias – Severe or symptomatic valvular disease – Other conditions that could be aggravated by exercise including, but not limited to, severe joint disease, uncontrolled diabetes, or uncontrolled hypertension To screen for exercise-induced myocardial ischemia & arrhythmias – Exercise stress testing is preferred – Careful questioning for symptoms is an alternative

Pre-Exercise Functional Evaluation May be either – Formal treadmill testing protocols – Observation during initial treadmill exercise session Goal is to determine – Claudication threshold – Cardiovascular response to exercise – Establish parameters for the exercise prescription

Use of a Pain Scale in PAD Exercise Rehabilitation 1No Pain 2Onset of Pain 3Mild Pain 4Moderate 5Severe

PAD Exercise Guidelines Warm-up and cool-down: 5 minutes each Mode: Treadmill walking Intensity: Walk to claudication pain (3-4 of 5 on the scale), maintain for 8-10 min. Increase speed or grade when pain becomes less than moderate. Duration: Initially, accumulate 35 min of walking in bouts of 8-10 min each. Rest between bouts until pain subsides. Progress to 50 min, including 5 minutes warm up and cool down. Frequency: 3-5 times/week Total Time: At least 3 months Source; Regensteiner and Hiatt: ACSM Resource Manual 2001.

Specifics About Exercise Prescription The initial training intensity is defined as the % inclination that brings on the onset of claudication pain (level 2 of 5 on the claudication scale), with the initial speed set at 2.0 mph During the initial exercise session – Participants walk to a mild to moderate pain level (3-4 of 5 on the claudication scale) at the initial training intensity above, then – Stop and rest until the claudication pain has completely abated and then – Resume walking at the initial training intensity again

Goals of the Initial Training Sessions For the participant to understand the claudication scale, foot care, and purpose of exercise training To teach warm up and cool down principles To accumulate 15 minutes or more of total exercise treadmill time, excluding warm up and cool down

Goal of Subsequent Exercise Sessions Cumulative exercise session of 50 minutes (including rest periods) Advance speed and inclination over time to maintain a claudication stimulus to exercise training Warm-up and cool-down periods of 5 minutes each Total of 60 minutes per session

Progression of the Exercise Training Intensity Should occur during the session after the participant can exercise for – at least 8 minutes without stopping for 3-4/5 claudication pain – cumulative exercise duration of 50 minutes including rest periods Increase inclination by 1-2% maintain the same speed (2.0 mph)

General Guidelines for Progression of Exercise Training Intensity During Rehabilitation Continue to increase inclination as tolerated in subsequent sessions until reach 10% at 2.0 mph Then increase speed by 0.1 to 0.2 mph at 10% with goal to achieve more than 8 minutes before rest is needed for claudication pain (3-4/5) When reach 3.0 mph/10% inclination, then increase inclination by 1-2%, up to 15% Final step is to increase speed by 0.1 to 0.2 mph increments as tolerated

Case Study: History & Clinical Profile 70 year old white female Wt: 180 lbs. Ht: 62” BMI = 32.9 Current smoker: 1/2 pack per day Hyperlipidemia, hypertension Cardiac History: CABG January, 2004, and NSTEMI June, 2006

Pertinent medical hx: Bilateral PAD Current meds: cilostazol, lisinopril, furosemide, simvastatin, clopidogrel, aspirin Resting BP: 128/46; RHR: 64 Resting ECG: Non-specific ST-T wave  ‘s Case Study: History & Clinical Profile

Exercise Test Results Onset of leg 2.0 mph / 7% grade Maximal 2.0 mph / 10.5% grade Normal BP & HR response No complaints of angina Stress ECG: No changes Case Study: History & Clinical Profile

What is the beginning exercise prescription? Case Study: Exercise Training Scenarios

What is the beginning exercise prescription? Treadmill walking at 2 mph / 7% grade Walk to moderate pain (3 or 4 on scale) Case Study: Exercise Training Scenarios

After development of a 3 or 4 on the claudication pain scale, the Participant stops walking and sits. How long does she rest until resuming treadmill exercise? A. 2 minutes B. 5 minutes C. Until pain is no longer mild or moderate D. Until pain is gone completely Case Study: Exercise Training Scenarios

After development of a 3 or 4 on the claudication pain scale, the Participant stops walking and sits. How long does she rest until resuming treadmill exercise? A. 2 minutes B. 5 minutes C. Until pain is no longer mild or moderate D. Until pain is gone completely Case Study: Exercise Training Scenarios

During the first 12 exercise sessions Participant progresses from 2.0 mph/7% grade to a workload of 2.0 mph / 10% grade. During sessions 13 – 24, the maximum walking time at 2.0 mph/10% grade was 7 min. What is the prescribed workload for session #25? A. 2.0 mph / 10% grade B. 2.2 mph / 10% grade C. 2.0 mph / 12% grade D. 2.5 mph / 10% grade Case Study: Exercise Training Scenarios

During the first 12 exercise sessions Participant progresses from 2.0 mph/7% grade to a workload of 2.0 mph / 10% grade. During sessions 13 – 24, the maximum walking time at 2.0 mph/10% grade was 7 min. What is the prescribed workload for session #25? A. 2.0 mph / 10% grade B. 2.2 mph / 10% grade C. 2.0 mph / 12% grade D. 2.5 mph / 10% grade

Other Program Considerations Treadmill or other walking exercise is the cornerstone. – If possible it should be used during each exercise session Other forms of exercise can also be added for cardiovascular health but have not been shown to improve claudication symptoms Invite participants to join your facility’s CV risk factor education sessions

Interventional Treatment Surgical or percutaneous intervention is recommended to treat: – ischemic rest pain – tissue loss – vocational limiting claudication Further information is available at – – %20-20Revascularization%20for%20Individual%20with%20PAD%20- %20the%20Symptomatic%20Leg.PPT

Post Interventional Considerations Avoid compression garments if ABI<0.8 If stents, avoid extended squatting or exercises that may compress the stent Avoid walking if plantar foot wound Observe for recurrent symptoms and notify health care provider if these occur Stress importance of excellent foot care

Assessing Participant Outcomes and Program Effectiveness Treadmill Testing Six Minute Walk Test Shuttle Walk Test Four Meter Walking Velocity Repeated Chair Rise Standing Balance Quality of Life Questionnaire Program Demographics Attendance

Marketing Considerations Surgeons are generally aware of the benefits of exercise training for IC but do not think about or know how to refer participants to programs Medical physicians are not always aware of benefits of exercise for these patients Clinical practice guidelines stress discussion of supervised exercise training with patients with IC Capture this marketing opportunity!

Keys to Successful Programs Efficient use of staff and equipment Build on successful existing programs Feasible business plan with enthusiastic support by administration Effective communication with referring physicians Awareness that successful marketing depends on every team member

PAD Coalition AACVPR